Shu-Sen Wang

423 total citations
8 papers, 300 citations indexed

About

Shu-Sen Wang is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shu-Sen Wang has authored 8 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Shu-Sen Wang's work include Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Breast Lesions and Carcinomas (2 papers). Shu-Sen Wang is often cited by papers focused on Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (2 papers) and Breast Lesions and Carcinomas (2 papers). Shu-Sen Wang collaborates with scholars based in China, Brazil and United States. Shu-Sen Wang's co-authors include Roujun Peng, Zhong-Yu Yuan, Tao Qin, Fei Xu, Xin-Ke Zhang, Ge Qin, Cong Xue, Jia-Bin Lu, Li Zhang and Yin-duo Zeng and has published in prestigious journals such as The Lancet Oncology, Oncotarget and Journal of Cancer Research and Clinical Oncology.

In The Last Decade

Shu-Sen Wang

8 papers receiving 299 citations

Peers

Shu-Sen Wang

ONCOL

CR

PFM

DERMA

IMMUN

Shiguang Zhu China

Tyler Izatt United States

Brian C. Willis United States

Dominique J P van Uden Netherlands

Kristina Hinz Germany

Jaylen M. Powell United States

Rebecca Jaslow United States

Ji Shin Lee South Korea

Zifen Gao China

Hyein Ahn South Korea

Shiguang Zhu China

Shu-Sen Wang

104 ×0.6

ONCOL

90 ×0.8

CR

65 ×0.7

PFM

13 ×0.2

DERMA

76 ×1.5

IMMUN

Citations per year, relative to Shu-Sen Wang Shu-Sen Wang (= 1×) peers Shiguang Zhu

Countries citing papers authored by Shu-Sen Wang

Since Specialization

Citations

This map shows the geographic impact of Shu-Sen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Sen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Sen Wang more than expected).

Fields of papers citing papers by Shu-Sen Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu-Sen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Sen Wang. The network helps show where Shu-Sen Wang may publish in the future.

Co-authorship network of co-authors of Shu-Sen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Sen Wang. A scholar is included among the top collaborators of Shu-Sen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Sen Wang. Shu-Sen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Yuan, Jing, Xi-Wen Bi, Hua Xin, et al.. (2025). Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial. The Lancet Oncology. 26(12). 1575–1583. 1 indexed citations

2.

Yang, Hang, Wen-Qi Jiang, Ye Cao, et al.. (2015). Elevated ZNF703 Protein Expression Is an Independent Unfavorable Prognostic Factor for Survival of the Patients with Head and Neck Squamous Cell Carcinoma. Disease Markers. 2015. 1–8. 9 indexed citations

3.

Qin, Tao, Yin-duo Zeng, Ge Qin, et al.. (2015). High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer. Oncotarget. 6(32). 33972–33981. 153 indexed citations

4.

Yuan, Zhong-Yu, Ting Dai, Shu-Sen Wang, et al.. (2014). Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets and Therapy. 7. 1733–1733. 35 indexed citations

5.

Yuan, Zhong-Yu, Dong Yang, Shu-Sen Wang, et al.. (2014). Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chinese Journal of Cancer. 33(10). 492–500. 65 indexed citations

6.

Shi, Yan-Xia, Qing Xia, Roujun Peng, et al.. (2012). Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer. Journal of Cancer Research and Clinical Oncology. 138(4). 705–714. 33 indexed citations

7.

Wang, Shu-Sen, et al.. (2008). [Clinical characteristics and prognosis of different subtypes of breast cancer].. PubMed. 30(6). 456–61. 2 indexed citations

8.

Wang, Shu-Sen & Ralph T. Yang. (1983). MULTICOMPONENT SEPARATION BY CYCLIC PROCESSES—A PROCESS FOR COMBINED HYDROGEN/METHANE SEPARATION AND ACID GAS REMOVAL IN COAL CONVERSION. Chemical Engineering Communications. 20(3-4). 183–189. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact